Mount Sinai Health System

Health System with 7 hospitals across 1 state

Health System Overview

Health System	Mount Sinai Health System
Total Hospitals	7
Commercial/Acute Hospitals	7
Total Beds	4751
Commercial/Acute Beds	4751
Headquarters	New York, NY
Website	mountsinai.org

Hospitals by Type

Acute Care Hospital

7 hospitals

100% of health system

Teaching Status

100%

Teaching

Teaching Hospitals: 7

Non-Teaching Hospitals:

Teaching hospitals serve as educational institutions for medical professionals while providing patient care.

Hospital Locations

Hospitals in this Health System

Hospital	Type	Beds	Teaching	Recently Joined
The Mount Sinai Hospital	Acute Care Hospital	1171	Yes	No
Richmond University Medical Center	Acute Care Hospital	473	Yes	No
Mount Sinai West	Acute Care Hospital	1028	Yes	No
The Brooklyn Hospital Center	Acute Care Hospital	464	Yes	No
New York Eye and Ear Infirmary of Mount Sinai	Acute Care Hospital	69	Yes	No
Mount Sinai Beth Israel	Acute Care Hospital	1111	Yes	No
Mount Sinai South Nassau	Acute Care Hospital	435	Yes	No

Recent News

Jun 11, 2025

A Mount Sinai-led study has demonstrated that the SGLT2 inhibitor empagliflozin is safe and effective in stabilizing kidney function in patients who have recently experienced a heart attack. This secondary analysis of the EMPACT-MI trial revealed that patients treated with empagliflozin for two years maintained stable kidney function, unlike those on a placebo who showed significant worsening. This finding is particularly important because many heart attack patients who could benefit from SGLT2 inhibitors do not receive them due to concerns about potential kidney damage in unstable patients. The study, published in Nature Cardiovascular Research, is the largest trial to date of an SGLT2 inhibitor in heart attack patients and its results may lead to changes in clinical practice, encouraging wider use of this beneficial drug. The research also found that empagliflozin reduced total hospitalizations for heart failure by 33 percent, with consistent effects regardless of kidney function.

Jun 10, 2025

Mount Sinai has received a significant $3.8 million grant aimed at studying new synthetic drugs and opioid overdoses within emergency departments. The funding will support research focused on understanding the impact of emerging synthetic drugs and developing strategies to prevent deaths related to opioid overdoses. This initiative highlights Mount Sinai's commitment to addressing the ongoing opioid crisis and the evolving landscape of substance abuse, with a focus on gathering crucial data from emergency room settings to inform better treatment and prevention methods. The grant will facilitate in-depth research into the pharmacological effects of these new substances and their clinical implications for patients presenting with overdoses.

Jun 10, 2025

Dermatologists at Mount Sinai are utilizing a novel technique involving tape strips to map immune changes in common skin diseases. This method allows researchers to collect samples from the skin's surface non-invasively, providing insights into the immunological processes underlying various dermatological conditions. By analyzing the molecular and cellular components gathered via tape stripping, the dermatologists aim to gain a better understanding of disease mechanisms and potentially identify new targets for therapeutic interventions. This approach offers a less painful and more accessible way to study skin immunity compared to traditional biopsy methods.

Jun 09, 2025

Mount Sinai Health System has been awarded several prestigious national honors for its commitment to environmental excellence. The health system received three top awards from Practice Greenhealth, a leading organization promoting environmental sustainability in healthcare. These accolades recognize Mount Sinai's significant progress in implementing environmentally responsible practices across its facilities and operations as part of its Mount Sinai Green program. The awards highlight the systemwide dedication to creating a healthier planet and improving patient well-being through sustainable initiatives. Mount Sinai was one of only 15 health systems nationwide to receive the System for Change Award, acknowledging its impactful environmental advancements and the integration of sustainability into its organizational culture and operations. [5]

Jun 08, 2025

Mount Sinai researchers presented groundbreaking findings at the SLEEP 2025 conference, held from June 8-11 in Seattle. Among the presented research was the development of a Transformer-based machine learning model designed to process full-night multichannel polysomnographic data. This model aims to predict cardiovascular mortality risk, representing a significant advancement in using artificial intelligence and biomedical data for predictive healthcare and the detection of cardiometabolic risks linked to sleep disorders.

Executive Leadership

No Contacts Found on Health System Web Page—HealthLuminate Provides Over 300K Hospital Leaders in Our Extended Database.